Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth
Cited by 148
Related Papers
S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism
|Nature Communications|2025|33
Inhibition of cFLIP overcomes acquired resistance to sorafenib via reducing ER stress‑related autophagy in hepatocellular carcinoma
|Oncology Reports|2018|25
Dipyridamole Acts as Clinical Ferroptosis Inhibitor to Prevent from Tissue Injury
|Advanced Science|2025|5